Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

BioCryst Pharmaceuticals Inc (BCRX)

Biological Products, (no Disgnostic Substances)

http://www.biocryst.com

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, with the aim of blocking key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

4505 EMPEROR BOULEVARD, SUITE 200
DURHAM, NC

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/03/1994

Market Cap

1,571,299,170

Shares Outstanding

204,810,000

Weighted SO

204,809,380

Total Employees

N/A

Upcoming Earnings

N/A

Beta

1.8790

Last Div

0.0000

Range

4.03-8.09

Chg

-0.0350

Avg Vol

3167720

Mkt Cap

1571299170

Exch

NASDAQ

Country

US

Phone

919 859 1302

DCF Diff

4.9255

DCF

15.5055

Div Yield

0.0000

P/S

4.1108

EV Multiple

-45.8678

P/FV

-3.2964

Div Yield %

0.0000

P/E

-10.7433

PEG

-0.3276

Payout

0.0000

Current Ratio

2.8161

Quick Ratio

2.7816

Cash Ratio

0.6214

DSO

65.6585

DIO

249.3093

Op Cycle

314.9678

DPO

436.2073

CCC

-121.2395

Gross Margin

0.9830

Op Margin

-0.1575

Pretax Margin

-0.3833

Net Margin

-0.3818

Eff Tax Rate

0.0038

ROA

-0.3089

ROE

0.1929

ROCE

-0.1753

NI/EBT

0.9962

EBT/EBIT

2.4339

EBIT/Rev

-0.1575

Debt Ratio

1.7784

D/E

-1.7665

LT Debt/Cap

2.4288

Total Debt/Cap

2.3046

Int Coverage

-0.5950

CF/Debt

-0.1003

Equity Multi

-0.9933

Rec Turnover

5.5591

Pay Turnover

0.8368

Inv Turnover

1.4640

FA Turnover

18.9978

Asset Turnover

0.8091

OCF/Share

-0.4082

FCF/Share

-0.4176

Cash/Share

1.3265

OCF/Sales

-0.2205

FCF/OCF

1.0229

CF Coverage

-0.1003

ST Coverage

-2.6599

CapEx Coverage

-43.6401

Div&CapEx Cov

-43.6401

P/BV

-3.2964

P/B

-3.2964

P/S

4.1108

P/E

-10.7433

P/FCF

-18.2285

P/OCF

-18.6047

P/CF

-18.6047

PEG

-0.3276

P/S

4.1108

EV Multiple

-45.8678

P/FV

-3.2964

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation